Next |
home / stock / arvn / arvn message board
Subject | By | Source | When |
---|---|---|---|
ARVN up 138% > Based on data to | crudeoil24 | investorshub | 12/14/2020 2:19:37 PM |
Advantages of PROTACs vs. inhibition... | biocqr | investorshub | 12/17/2019 3:29:22 PM |
Idk about that, I thought it had some | G-lupo | investorshub | 11/29/2019 5:15:41 AM |
Starting to see a chink in the armor! | boo boo | investorshub | 11/26/2019 10:04:01 PM |
Possibly wall at 30.50 | G-lupo | investorshub | 11/15/2019 10:01:32 PM |
I feel people are going to start taking | G-lupo | investorshub | 11/14/2019 6:08:24 PM |
The offering: | boo boo | investorshub | 11/14/2019 3:19:51 PM |
Benzinga 11/14/2019: | boo boo | investorshub | 11/14/2019 3:05:47 PM |
It doesn't have to be a PR: | boo boo | investorshub | 11/13/2019 5:53:07 PM |
Thanks, Im in it, thought $28 would be | G-lupo | investorshub | 11/13/2019 5:47:45 PM |
https://polsonnews.com/arvinas-inc-nasdaqarvn-receives-34-33-average-pt-fro | boo boo | investorshub | 11/13/2019 4:11:25 PM |
When did they Do a price target announcement? | G-lupo | investorshub | 11/13/2019 4:03:44 PM |
If I were in this one (I'm not), | boo boo | investorshub | 11/13/2019 3:14:32 PM |
Arvn looking good, defintely see $26-27 | G-lupo | investorshub | 11/05/2019 10:05:43 PM |
What you mean IBD? | G-lupo | investorshub | 10/29/2019 3:53:07 PM |
Not me. I look for the trade | boo boo | investorshub | 10/29/2019 3:12:40 PM |
I agree I own a decent amount, purchased | G-lupo | investorshub | 10/29/2019 3:05:40 PM |
Missing a trade and people who post a | boo boo | investorshub | 10/29/2019 2:06:03 PM |
What are you talking about ? Saw the | G-lupo | investorshub | 10/29/2019 1:30:45 AM |
Screwed this one up. More and better | boo boo | investorshub | 10/25/2019 8:07:29 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-12 08:30:02 ET H.C. Wainwright analyst issues BUY recommendation for ARVN on April 12, 2024 06:52AM ET. The previous analyst recommendation was Buy. ARVN was trading at $37.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...
2024-04-11 13:00:02 ET Bradley Canino from Stifel Nicolaus issued a price target of $72.00 for ARVN on 2024-04-11 09:35:00. The adjusted price target was set to $72.00. At the time of the announcement, ARVN was trading at $38.73. The overall price target consensus is at ...
2024-04-11 11:31:00 ET Arvinas Inc (NASDAQ: ARVN) is in the green at writing after announcing a deal worth over $1.0 billion with Novartis (SWX: NOVN). Details of Arvinas – Novartis agreement Novartis will pay $150 million to the pharmaceutical company up front. In return...